The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(S,E)-3-(5-Chloro-2-(1H-tetrazol-1-yl)phenyl)-N-(1-(5-chloro-4-(4-hydroxy-2-oxo-1,2-dihydroquinolin-6-yl)-1H-imidazol-2-yl)-3-(4-methylpiperazin-1-yl)-3-oxopropyl)acrylamide hydrochloride ID: ALA3580760
PubChem CID: 122178428
Max Phase: Preclinical
Molecular Formula: C30H29Cl3N10O4
Molecular Weight: 663.53
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: CN1CCN(C(=O)C[C@H](NC(=O)/C=C/c2cc(Cl)ccc2-n2cnnn2)c2nc(-c3ccc4[nH]c(=O)cc(O)c4c3)c(Cl)[nH]2)CC1.Cl
Standard InChI: InChI=1S/C30H28Cl2N10O4.ClH/c1-40-8-10-41(11-9-40)27(46)14-22(35-25(44)7-3-17-12-19(31)4-6-23(17)42-16-33-38-39-42)30-36-28(29(32)37-30)18-2-5-21-20(13-18)24(43)15-26(45)34-21;/h2-7,12-13,15-16,22H,8-11,14H2,1H3,(H,35,44)(H,36,37)(H2,34,43,45);1H/b7-3+;/t22-;/m0./s1
Standard InChI Key: PKVVLVYNVQAUEP-BWHJXNDYSA-N
Molfile:
RDKit 2D
47 51 0 0 0 0 0 0 0 0999 V2000
6.3926 5.2106 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
-12.9551 4.1532 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.9403 9.0048 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.3390 10.3790 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.1518 10.5453 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0412 9.3375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.4399 7.9632 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0509 7.7970 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.6526 6.4221 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.8876 5.1467 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8859 4.0271 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.2591 4.6307 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.1095 6.1232 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.6329 11.6447 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
-1.3322 6.7565 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.8236 6.9250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.7159 5.7182 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.2073 5.8867 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-3.2367 4.6181 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-6.0996 4.6800 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.5014 3.3065 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-7.5910 4.8485 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-8.4833 3.6418 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.2601 2.0125 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-5.2640 0.8910 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.9086 1.5029 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.0363 2.9847 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-5.5144 -0.2825 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
-2.6111 0.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2964 1.4973 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2964 -1.4973 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.6111 -0.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6321 -1.3486 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-9.9746 3.8103 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-8.0041 2.5416 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-10.8683 2.6055 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-12.3585 2.7769 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-12.0615 5.3580 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-10.5714 5.1866 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-14.1472 4.2903 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 -0.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 0.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2964 1.4973 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5929 0.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5929 -0.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2964 -1.4973 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.2964 2.6973 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3 4 2 0
4 5 1 0
5 6 2 0
6 7 1 0
7 8 2 0
8 3 1 0
9 10 1 0
10 11 2 0
11 12 1 0
12 13 2 0
13 9 1 0
8 9 1 0
5 14 1 0
7 15 1 0
15 16 2 0
16 17 1 0
17 18 1 0
17 19 2 0
18 20 1 0
20 21 1 0
20 22 1 6
22 23 1 0
21 24 1 0
24 25 1 0
25 26 2 0
26 27 1 0
27 21 2 0
25 28 1 0
26 29 1 0
29 30 2 0
30 42 1 0
41 31 1 0
31 32 2 0
32 29 1 0
45 33 2 0
23 34 1 0
23 35 2 0
34 36 1 0
34 39 1 0
36 37 1 0
37 2 1 0
2 38 1 0
38 39 1 0
2 40 1 0
41 42 2 0
41 46 1 0
42 43 1 0
43 44 2 0
44 45 1 0
45 46 1 0
43 47 1 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 663.53Molecular Weight (Monoisotopic): 662.1672AlogP: 2.94#Rotatable Bonds: 8Polar Surface Area: 178.02Molecular Species: NEUTRALHBA: 10HBD: 4#RO5 Violations: 1HBA (Lipinski): 14HBD (Lipinski): 4#RO5 Violations (Lipinski): 2CX Acidic pKa: 6.61CX Basic pKa: 7.25CX LogP: 0.78CX LogD: 0.66Aromatic Rings: 5Heavy Atoms: 46QED Weighted: 0.18Np Likeness Score: -1.35
References 1. Hu Z, Wong PC, Gilligan PJ, Han W, Pabbisetty KB, Bozarth JM, Crain EJ, Harper T, Luettgen JM, Myers JE, Ramamurthy V, Rossi KA, Sheriff S, Watson CA, Wei A, Zheng JJ, Seiffert DA, Wexler RR, Quan ML.. (2015) Discovery of a Potent Parenterally Administered Factor XIa Inhibitor with Hydroxyquinolin-2(1H)-one as the P2' Moiety., 6 (5): [PMID:26005539 ] [10.1021/acsmedchemlett.5b00066 ]